Supporting Dewpoint’s novel condensate modulating approach to drug previously ‘undruggable’ therapeutic targets, guided by ...
The collaboration is another vote of confidence in Dewpoint’s biomolecular condensates research, which had already attracted ...
Dewpoint Therapeutics and Mitsubishi Tanabe Pharma Corporation (MTPC) have entered a strategic research partnership focusing ...
As part of the deal, Dewpoint can expect an undisclosed upfront payment from Mitsubishi Tanabe Pharma Corporation (MTPC) in ...
Mitsubishi Tanabe Pharma is offering Dewpoint Therapeutics up to $480 million biobucks in a new research pact centering ...
Dewpoint Therapeutics Inc. and Mitsubishi Tanabe Pharma Corp. have entered a research collaboration worth up to $480 million ...
Privately-held Dewpoint Therapeutics, a Boston, USA, biotech developing therapeutics by targeting biomolecular condensates, ...
Both companies will collaborate to advance a small molecule condensate modulator targeting TDP-43, with the potential to ...
Biotechnology company Dewpoint Therapeutics is translating condensate science into breakthrough medicine for diseases with high unmet need. Dewpoint has built an artificial intelligence (AI ...
How fog is formed actually has a lot to do with a map that you see us use a lot, the dewpoint map. Fog occurs when the temperature at the surface matches up with the dewpoint value. What this ...
Under the terms of the agreement, Dewpoint will receive an upfront payment and will be eligible for milestone payments based on specified near-term research and development objectives, with a total ...